126 related articles for article (PubMed ID: 12063036)
1. Role of vitronectin receptor-type integrins and osteopontin in ischemia-induced retinal neovascularization.
Takagi H; Suzuma K; Otani A; Oh H; Koyama S; Ohashi H; Watanabe D; Ojima T; Suganami E; Honda Y
Jpn J Ophthalmol; 2002; 46(3):270-8. PubMed ID: 12063036
[TBL] [Abstract][Full Text] [Related]
2. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
[TBL] [Abstract][Full Text] [Related]
3. Expression of thrombospondin-1 in ischemia-induced retinal neovascularization.
Suzuma K; Takagi H; Otani A; Oh H; Honda Y
Am J Pathol; 1999 Feb; 154(2):343-54. PubMed ID: 10027393
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine retinal microvascular endothelial cells.
Suzuma K; Takagi H; Otani A; Honda Y
Invest Ophthalmol Vis Sci; 1998 May; 39(6):1028-35. PubMed ID: 9579483
[TBL] [Abstract][Full Text] [Related]
5. The 67-kd laminin receptor is preferentially expressed by proliferating retinal vessels in a murine model of ischemic retinopathy.
Stitt AW; McKenna D; Simpson DA; Gardiner TA; Harriott P; Archer DB; Nelson J
Am J Pathol; 1998 May; 152(5):1359-65. PubMed ID: 9588904
[TBL] [Abstract][Full Text] [Related]
6. Expression and activation of STAT3 in ischemia-induced retinopathy.
Mechoulam H; Pierce EA
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4409-16. PubMed ID: 16303927
[TBL] [Abstract][Full Text] [Related]
7. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization.
Takagi H; Koyama S; Seike H; Oh H; Otani A; Matsumura M; Honda Y
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):393-402. PubMed ID: 12506101
[TBL] [Abstract][Full Text] [Related]
8. Regulation of alphaVbeta3 and alphaVbeta5 integrins by dexamethasone in normal human osteoblastic cells.
Cheng SL; Lai CF; Fausto A; Chellaiah M; Feng X; McHugh KP; Teitelbaum SL; Civitelli R; Hruska KA; Ross FP; Avioli LV
J Cell Biochem; 2000 Mar; 77(2):265-76. PubMed ID: 10723092
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 (PAI-1) facilitates retinal angiogenesis in a model of oxygen-induced retinopathy.
Basu A; Menicucci G; Maestas J; Das A; McGuire P
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4974-81. PubMed ID: 19443721
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin and its integrin receptor alpha(v)beta3 are upregulated during formation of the glial scar after focal stroke.
Ellison JA; Velier JJ; Spera P; Jonak ZL; Wang X; Barone FC; Feuerstein GZ
Stroke; 1998 Aug; 29(8):1698-706; discussion 1707. PubMed ID: 9707214
[TBL] [Abstract][Full Text] [Related]
11. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.
Pierce EA; Foley ED; Smith LE
Arch Ophthalmol; 1996 Oct; 114(10):1219-28. PubMed ID: 8859081
[TBL] [Abstract][Full Text] [Related]
12. Increased retinal neovascularization in Fas ligand-deficient mice.
Davies MH; Eubanks JP; Powers MR
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3202-10. PubMed ID: 12824272
[TBL] [Abstract][Full Text] [Related]
13. alphavbeta3, alphavbeta5, and osteopontin are coordinately upregulated at early time points in a rabbit model of neointima formation.
Corjay MH; Diamond SM; Schlingmann KL; Gibbs SK; Stoltenborg JK; Racanelli AL
J Cell Biochem; 1999 Dec; 75(3):492-504. PubMed ID: 10536371
[TBL] [Abstract][Full Text] [Related]
14. Relationship between Pericytes and Endothelial Cells in Retinal Neovascularization: A Histological and Immunofluorescent Study of Retinal Angiogenesis.
Choi SH; Chung M; Park SW; Jeon NL; Kim JH; Yu YS
Korean J Ophthalmol; 2018 Feb; 32(1):70-76. PubMed ID: 29376221
[TBL] [Abstract][Full Text] [Related]
15. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
[TBL] [Abstract][Full Text] [Related]
17. Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor.
Nagai N; Noda K; Urano T; Kubota Y; Shinoda H; Koto T; Shinoda K; Inoue M; Shiomi T; Ikeda E; Tsubota K; Suda T; Oike Y; Ishida S
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1078-84. PubMed ID: 15728568
[TBL] [Abstract][Full Text] [Related]
18. The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target.
McGuire PG; Jones TR; Talarico N; Warren E; Das A
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2736-42. PubMed ID: 12766081
[TBL] [Abstract][Full Text] [Related]
19. Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model.
Liu X; Wang D; Liu Y; Luo Y; Ma W; Xiao W; Yu Q
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3749-57. PubMed ID: 20207957
[TBL] [Abstract][Full Text] [Related]
20. Rofecoxib inhibits retinal neovascularization via down regulation of cyclooxygenase-2 and vascular endothelial growth factor expression.
Liu NN; Sun YZ; Zhao N; Chen L
Clin Exp Ophthalmol; 2015 Jul; 43(5):458-65. PubMed ID: 25472856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
